Calcium Phosphate as a Key Material for Socially Responsible Tissue Engineering
Vuk Uskoković1, Victoria M Wu2
1Department of Bioengineering, University of Illinois, Chicago, IL 60607-7052, USA ; Department of Biomedical and Pharmaceutical Sciences, Chapman University, Irvine, CA 92618-1908, USA.
Materials (Basel, Switzerland)
|June 28, 2016
Summary
Calcium phosphate nanoparticles offer a simplified, cost-effective solution for treating osteomyelitis, a prevalent disease in underserved regions. These versatile nanoparticles can be engineered to deliver therapeutics and possess inherent antimicrobial and bone-healing properties.
Area of Science:
- Biomaterials Science
- Nanotechnology
- Medical Engineering
Background:
- Socially responsible medical technologies prioritize accessibility and affordability in resource-limited settings.
- Osteomyelitis, particularly in its natural form, disproportionately affects underdeveloped regions with poor sanitation and compromised immunity.
- Current trends in therapeutic nanoparticles often lead to increased complexity and cost, hindering accessibility.
Purpose of the Study:
- To demonstrate the feasibility of simplifying therapeutic nanoparticle formulations for osteomyelitis treatment.
- To highlight the potential of calcium phosphate nanoparticles as a cost-effective and functional alternative to complex therapeutic systems.
- To explore the multifaceted therapeutic capabilities of calcium phosphates in addressing osteomyelitis.
Main Methods:
- Review of existing literature on calcium phosphate nanoparticles and their applications in bone diseases.
- Analysis of the chemical design possibilities for functionalizing calcium phosphates.
- Evaluation of the inherent properties of calcium phosphates relevant to osteomyelitis treatment.
Main Results:
- Calcium phosphate nanoparticles can be chemically designed to mimic the functionality of complex multi-component therapeutic systems.
- These nanoparticles exhibit tunable drug release profiles, injectable and self-setting properties, and osteo-inductive/inhibitory capabilities.
- Calcium phosphates possess inherent antimicrobial properties and can facilitate intracellular delivery of therapeutics, accommodate functional ions, and be processed for tissue engineering.
Conclusions:
- Calcium phosphate nanoparticles represent a promising, simplified, and affordable platform for socially responsible osteomyelitis therapy.
- Their inherent biological activities and design flexibility offer a broad therapeutic potential that is currently underexplored.
- Further research into calcium phosphate-based therapeutics can significantly improve treatment accessibility for endemic diseases in low-resource settings.
